Antibody Measurement Promises Smaller, Quicker Clinical Vaccine Trials - Health Dept.
Sumaira FH Published December 08, 2021 | 03:00 AM
WASHINGTON (UrduPoint News / Sputnik - 08th December, 2021) Antibody measurements shortly after people were vaccinated against COVID-19 revealed the potential for speedier clinical trials of new vaccine candidates with fewer participants, the National Institutes of Health (NIH) said.
"In people who received two doses of the Moderna COVID-19 vaccine, levels of antibodies found in the blood correlated with protection against illness," NIH said in a press release om Tuesday. "The findings show that measurement of certain antibody levels could allow for smaller, faster studies of vaccines against COVID-19 variants."
Researchers with the Fred Hutchinson Cancer Research Center measured antibodies of more than 1,000 Moderna COVID-19 vaccine recipients to look for associations between antibody levels and the risk of symptomatic breakthrough infections, the release said.
The team measured binding antibodies, which bind viruses to tag them for destruction, and neutralizing antibodies, which stop viruses from infecting cells by blocking the parts they need to enter, the release also said.
For people with no detectable neutralizing antibodies, the vaccine was only 51 percent effective. For people with the highest levels, it was 98 percent effective. Both types of antibodies had similar associations with vaccine effectiveness, the release added.
Researchers, however, said it is not yet known whether short-term antibody measures correlate with long-term protection, although study participants will be monitored for two years, according to the release.
Related Topics
Recent Stories
HEC reviews curricula for environmental sciences degree programme
ICC Asia looking forward to an action-packed Asia Cricket Week
Yuvraj Singh named ICC Men’s T20 World Cup 2024 Ambassador
Greece hands Olympic flame to 2024 Paris Games hosts
Two Kyiv hospitals evacuating over feared Russian strikes
World must act on neurotech revolution, say experts
Charles & Catherine's cancer diagnoses
Champions Alcaraz and Sabalenka through in Madrid Open
King Charles to resume some public duties during cancer treatment: palace
US defense chief announces $6 bn in security aid for Ukraine
Heavy rains cause damage to Spezand-Taftan railway track
Woman stabbed in Israel, attacker killed: police
More Stories From World
-
NFL will allow players to wear Guardian Cap helmets in games
4 hours ago -
Football: German Bundesliga table
4 hours ago -
Football: Italian Serie A result
4 hours ago -
Football: German Bundesliga results
4 hours ago -
US troops to leave Chad in second African state withdrawal
4 hours ago -
Plastics pollution may be solved without production cap: Canada minister
4 hours ago
-
Biden stalls on menthol cigarette ban fearing Black vote backlash
4 hours ago -
Champions Alcaraz and Sabalenka through in Madrid Open
4 hours ago -
6,000 French police to welcome Olympic torch amid bonus boost
5 hours ago -
Taiwan hit by several quakes, strongest reaching 6.1-magnitude
5 hours ago -
'Ballistic' Bairstow stars as Punjab pull off record T20 chase
5 hours ago -
Tennis: ATP/WTA Madrid Open results - 2nd update
5 hours ago